Patients Respond Well To First Study To Test Higher Doses Of An Anti-Cancer Drug
15th Nov 2006, 12:32 GMT
Researchers in the UK and the United States have found that a drug composed of an antibody carrying a highly toxic anti-cancer agent is well tolerated by patients at much higher doses than have been used before. [click link for full article]
Patients Respond Well To First Study To Test Higher Doses Of An Anti-Cancer Drug related news:
- Patients Respond Well To Higher Doses Of An Anti-cancer Drug - Limited Side Effects And Evidence Of Clinical Activity — Health News from Medical News Today
- Recurrent breast cancer: Drug shows promise — The Cancer Blog
- Drug That Interrupts A Key Stage Of Cell Division Shows Promise In Patients With Advanced Solid Tumours — Health News from Medical News Today
- Isis Soars on Cholesterol-Drug News — BusinessWeek Online --
- Drug That Interrupts A Key Stage Of Cell Division Shows Promise For Advanced Solid Tumors — Health News from Medical News Today
- Isis Says New Drug Effective Against Cholesterol — RedOrbit News - Health
- Quality care assessment examines surgical quality for colorectal cancer patients — EurekAlert! - Breaking News
- Anti-cancer drug shows early promise in pulmonary hypertension — EurekAlert! - Breaking News
- NICE refuses to fund £20,000 cancer drug available in Scotland — the Mail online | Home
- Anticoagulant-Antidote Pairing Passes 1st Human Safety Test (HealthDay) — Yahoo! Health: Health News
Latest news from Health News from Medical News Today:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes